IS2081B - Nýir þrombínhemlar, framleiðsla þeirra og notkun - Google Patents

Nýir þrombínhemlar, framleiðsla þeirra og notkun

Info

Publication number
IS2081B
IS2081B IS4639A IS4639A IS2081B IS 2081 B IS2081 B IS 2081B IS 4639 A IS4639 A IS 4639A IS 4639 A IS4639 A IS 4639A IS 2081 B IS2081 B IS 2081B
Authority
IS
Iceland
Prior art keywords
production
thrombin inhibitors
new thrombin
new
inhibitors
Prior art date
Application number
IS4639A
Other languages
English (en)
Other versions
IS4639A (is
Inventor
Gustafsson David
Nyström Jan-Erik
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9502487A external-priority patent/SE9502487D0/xx
Priority claimed from SE9502504A external-priority patent/SE9502504D0/xx
Priority claimed from SE9502505A external-priority patent/SE9502505D0/xx
Priority claimed from SE9503923A external-priority patent/SE9503923D0/xx
Priority claimed from SE9504349A external-priority patent/SE9504349D0/xx
Priority claimed from GBGB9526411.5A external-priority patent/GB9526411D0/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IS4639A publication Critical patent/IS4639A/is
Publication of IS2081B publication Critical patent/IS2081B/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
IS4639A 1995-07-06 1997-12-22 Nýir þrombínhemlar, framleiðsla þeirra og notkun IS2081B (is)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
SE9502487A SE9502487D0 (sv) 1995-07-06 1995-07-06 New amino acid derivatives
SE9502504A SE9502504D0 (sv) 1995-07-07 1995-07-07 New amino acid derivatives
SE9502505A SE9502505D0 (sv) 1995-07-07 1995-07-07 New amino acid derivatives
SE9503923A SE9503923D0 (sv) 1995-11-07 1995-11-07 New amino acid derivatives
SE9504349A SE9504349D0 (sv) 1995-12-05 1995-12-05 New amino acid derivatives
GBGB9526411.5A GB9526411D0 (en) 1995-12-22 1995-12-22 Compounds
PCT/SE1996/000878 WO1997002284A1 (en) 1995-07-06 1996-07-02 New thrombin inhibitors, their preparation and use

Publications (2)

Publication Number Publication Date
IS4639A IS4639A (is) 1997-12-22
IS2081B true IS2081B (is) 2006-02-15

Family

ID=27547251

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4639A IS2081B (is) 1995-07-06 1997-12-22 Nýir þrombínhemlar, framleiðsla þeirra og notkun

Country Status (31)

Country Link
US (4) US6051568A (is)
EP (1) EP0836615B1 (is)
JP (1) JP4107682B2 (is)
KR (1) KR100435008B1 (is)
CN (1) CN1147504C (is)
AR (1) AR003440A1 (is)
AT (1) ATE238342T1 (is)
AU (1) AU709710B2 (is)
BR (1) BR9609447A (is)
CA (1) CA2226256C (is)
CZ (1) CZ298487B6 (is)
DE (1) DE69627659T2 (is)
DK (1) DK0836615T3 (is)
EE (1) EE04500B1 (is)
ES (1) ES2197240T3 (is)
HK (1) HK1008995A1 (is)
HU (1) HUP9802315A3 (is)
IL (1) IL122813A0 (is)
IS (1) IS2081B (is)
MX (1) MX9800146A (is)
MY (1) MY116539A (is)
NO (1) NO324092B1 (is)
NZ (2) NZ509474A (is)
PL (1) PL185606B1 (is)
PT (1) PT836615E (is)
RU (1) RU2176645C2 (is)
SA (1) SA96170106A (is)
SI (1) SI0836615T1 (is)
SK (1) SK284695B6 (is)
TR (1) TR199800009T1 (is)
WO (1) WO1997002284A1 (is)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SA96170106A (ar) * 1995-07-06 2005-12-03 أسترا أكتيبولاج مشتقات حامض أميني جديدة
SE9602263D0 (sv) 1996-06-07 1996-06-07 Astra Ab New amino acid derivatives
US6200967B1 (en) 1996-06-25 2001-03-13 Eli Lilly And Company Anticoagulant agents
US5863929A (en) * 1996-06-25 1999-01-26 Eli Lilly And Company Anticoagulant agents
SE9602646D0 (sv) 1996-07-04 1996-07-04 Astra Ab Pharmaceutically-useful compounds
AR013084A1 (es) 1997-06-19 2000-12-13 Astrazeneca Ab Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados
SE9704543D0 (sv) 1997-12-05 1997-12-05 Astra Ab New compounds
US6417161B1 (en) 1998-04-24 2002-07-09 3-Dimensional Pharmaceuticals, Inc. Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors
SE9802938D0 (sv) 1998-09-01 1998-09-01 Astra Ab Improved stability for injection solutions
WO2000031078A1 (fr) * 1998-11-20 2000-06-02 Banyu Pharmaceutical Co., Ltd. Derives de 1-acetylazetidine
SE9804313D0 (sv) 1998-12-14 1998-12-14 Astra Ab New compounds
WO2000042059A1 (en) 1999-01-13 2000-07-20 Astrazeneca Ab New amidinobenzylamine derivatives and their use as thrombin inhibitors
AR023510A1 (es) 1999-04-21 2002-09-04 Astrazeneca Ab Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina.
SE0001803D0 (sv) * 2000-05-16 2000-05-16 Astrazeneca Ab New compounds i
MXPA03000643A (es) * 2000-08-16 2003-06-06 Astrazeneca Ab Nuevos derivados de amidino y su uso como inhibidores de trombina.
US6433186B1 (en) 2000-08-16 2002-08-13 Astrazeneca Ab Amidino derivatives and their use as thormbin inhibitors
US7129233B2 (en) 2000-12-01 2006-10-31 Astrazeneca Ab Mandelic acid derivatives and their use as thrombin inhibitors
SE0102921D0 (sv) * 2001-08-30 2001-08-30 Astrazeneca Ab Pharmaceutically useful compounds
AR035216A1 (es) * 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
US6528503B2 (en) * 2000-12-18 2003-03-04 Merck & Co., Inc. Thrombin inhibitors
US7144899B2 (en) * 2001-02-09 2006-12-05 Merck & Co., Inc. Thrombin inhibitors
SE0101762D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab New use
AR034517A1 (es) * 2001-06-21 2004-02-25 Astrazeneca Ab Formulacion farmaceutica
UA78195C2 (uk) * 2001-08-30 2007-03-15 Astrazeneca Ab Похідні мигдалевої кислоти та їх застосування як інгібіторів тромбіну, фармацевтична композиція на їх основі
SE0201661D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab New salts
SE0201658D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab Immediate release pharmaceutical formulation
SE0201659D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab Modified release pharmaceutical formulation
US7781424B2 (en) * 2003-05-27 2010-08-24 Astrazeneca Ab Modified release pharmaceutical formulation
US7524354B2 (en) * 2005-07-07 2009-04-28 Research Foundation Of State University Of New York Controlled synthesis of highly monodispersed gold nanoparticles
TW200827336A (en) 2006-12-06 2008-07-01 Astrazeneca Ab New crystalline forms
US20090061000A1 (en) * 2007-08-31 2009-03-05 Astrazeneca Ab Pharmaceutical formulation use 030

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU178398B (en) * 1979-06-12 1982-04-28 Gyogyszerkutato Intezet Process for producing new agmatine derivatives of activity against haemagglutination
HU192646B (en) * 1984-12-21 1987-06-29 Gyogyszerkutato Intezet Process for preparing new n-alkyl-peptide aldehydes
ZA86746B (en) * 1985-02-04 1986-09-24 Merrell Dow Pharma Novel peptidase inhibitors
US5187157A (en) * 1987-06-05 1993-02-16 Du Pont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
EP0362002B1 (en) * 1988-09-01 1995-07-26 Merrell Dow Pharmaceuticals Inc. HIV protease inhibitors
ZA897515B (en) * 1988-10-07 1990-06-27 Merrell Dow Pharma Novel peptidase inhibitors
TW201303B (is) * 1990-07-05 1993-03-01 Hoffmann La Roche
CA2075154A1 (en) * 1991-08-06 1993-02-07 Neelakantan Balasubramanian Peptide aldehydes as antithrombotic agents
SE9102462D0 (sv) * 1991-08-28 1991-08-28 Astra Ab New isosteric peptides
NZ245039A (en) * 1991-11-12 1994-12-22 Lilly Co Eli N-phenylalanyl and n-phenylglycyl derivatives of the dipeptide of l-azetidine-2-carboxylic acid and l-arginine aldehyde; anti-blood clotting compositions
SE9103612D0 (sv) * 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
CA2131367A1 (en) * 1992-03-04 1993-09-16 Sandor Bajusz New anticoagulant peptide derivatives and pharmaceutical compositions containing the same as well as a process for the preparation thereof
TW223629B (is) 1992-03-06 1994-05-11 Hoffmann La Roche
US5519193A (en) 1992-10-27 1996-05-21 International Business Machines Corporation Method and apparatus for stressing, burning in and reducing leakage current of electronic devices using microwave radiation
AU675981B2 (en) * 1992-12-02 1997-02-27 Bristol-Myers Squibb Company Guanidinyl-substituted heterocyclic thrombin inhibitors
US5583146A (en) * 1992-12-02 1996-12-10 Bristol-Myers Squibb Company Heterocyclic thrombin inhibitors
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
US5783563A (en) * 1993-06-03 1998-07-21 Astra Aktiebolag Method for treatment or prophylaxis of venous thrombosis
DE4321444A1 (de) * 1993-06-28 1995-01-05 Bernd Prof Dr Clement Pharmazeutische Zubereitung
EP0648780A1 (en) * 1993-08-26 1995-04-19 Bristol-Myers Squibb Company Heterocyclic thrombin inhibitors
TW394760B (en) * 1993-09-07 2000-06-21 Hoffmann La Roche Novel Carboxamides, process for their preparation and pharmaceutical composition containing the same
CA2140598C (en) * 1994-01-27 2010-03-09 Masahiro Ohshima Prolineamide derivatives
US5707966A (en) * 1994-03-04 1998-01-13 Eli Lilly And Company Antithrombotic agents
US5726159A (en) * 1994-03-04 1998-03-10 Eli Lilly And Company Antithrombotic agents
ZA951617B (en) * 1994-03-04 1997-02-27 Lilly Co Eli Antithrombotic agents.
US5705487A (en) * 1994-03-04 1998-01-06 Eli Lilly And Company Antithrombotic agents
US5561146A (en) * 1994-06-10 1996-10-01 Bristol-Myers Squibb Company Modified guanidino and amidino thrombin inhibitors
DE4421052A1 (de) * 1994-06-17 1995-12-21 Basf Ag Neue Thrombininhibitoren, ihre Herstellung und Verwendung
US5510369A (en) * 1994-07-22 1996-04-23 Merck & Co., Inc. Pyrrolidine thrombin inhibitors
EP0794777A1 (en) * 1994-11-24 1997-09-17 Janssen Pharmaceutica N.V. Lubeluzole intravenous solutions
NZ302649A (en) * 1995-02-17 2000-01-28 Basf Ag Dipeptide amidine derivatives, preparation and pharmaceutical compositions thereof
US5710130A (en) * 1995-02-27 1998-01-20 Eli Lilly And Company Antithrombotic agents
US5629324A (en) * 1995-04-10 1997-05-13 Merck & Co., Inc. Thrombin inhibitors
SA96170106A (ar) * 1995-07-06 2005-12-03 أسترا أكتيبولاج مشتقات حامض أميني جديدة
SE9602263D0 (sv) * 1996-06-07 1996-06-07 Astra Ab New amino acid derivatives

Also Published As

Publication number Publication date
HUP9802315A3 (en) 1999-03-01
TR199800009T1 (xx) 1998-05-21
AU6325396A (en) 1997-02-05
EE9700354A (et) 1998-06-15
NO980015L (no) 1998-02-25
IS4639A (is) 1997-12-22
EP0836615A1 (en) 1998-04-22
BR9609447A (pt) 1999-03-02
HK1008995A1 (en) 1999-05-21
DE69627659T2 (de) 2004-03-04
MY116539A (en) 2004-02-28
ES2197240T3 (es) 2004-01-01
KR100435008B1 (ko) 2004-07-16
NZ509474A (en) 2005-08-26
IL122813A0 (en) 1998-08-16
SK284695B6 (sk) 2005-09-08
US6051568A (en) 2000-04-18
CN1195354A (zh) 1998-10-07
CZ421297A3 (cs) 1998-06-17
DE69627659D1 (de) 2003-05-28
EE04500B1 (et) 2005-06-15
ATE238342T1 (de) 2003-05-15
CN1147504C (zh) 2004-04-28
MX9800146A (es) 1998-03-31
CA2226256C (en) 2008-12-30
JP4107682B2 (ja) 2008-06-25
PL324483A1 (en) 1998-05-25
US6337343B1 (en) 2002-01-08
US6921758B2 (en) 2005-07-26
CZ298487B6 (cs) 2007-10-17
NZ311854A (en) 2000-06-23
HUP9802315A2 (hu) 1999-01-28
AR003440A1 (es) 1998-08-05
PT836615E (pt) 2003-09-30
AU709710B2 (en) 1999-09-02
PL185606B1 (pl) 2003-06-30
KR19990028755A (ko) 1999-04-15
EP0836615B1 (en) 2003-04-23
US6617320B2 (en) 2003-09-09
SK180497A3 (en) 1998-11-04
CA2226256A1 (en) 1997-01-23
JPH11508591A (ja) 1999-07-27
WO1997002284A1 (en) 1997-01-23
DK0836615T3 (da) 2003-08-11
NO980015D0 (no) 1998-01-02
SA96170106A (ar) 2005-12-03
SI0836615T1 (en) 2003-10-31
US20040087647A1 (en) 2004-05-06
RU2176645C2 (ru) 2001-12-10
US20020042396A1 (en) 2002-04-11
NO324092B1 (no) 2007-08-13

Similar Documents

Publication Publication Date Title
IS2081B (is) Nýir þrombínhemlar, framleiðsla þeirra og notkun
FI973282A (fi) Trombiinin inhibiittoreita
DK0858464T3 (da) Thrombin-inhibitorer
NO981938D0 (no) Proteaseinhibitorer
NO985820D0 (no) Cytokinproduksjonsinhibitor, triazepinforbindelse og mellomprodukter for disse
IS1839B (is) Píperasín afleiður sem hafa verkjastillandi áhrif, framleiðsla og notkun þeirra
IS8717A (is) Ísókínólín og framleiðsla þeirra
NO973519L (no) Fleravtapnings- bore- og produksjonsinnretning
IS4930A (is) Nýjar amidínóafleiður og notkun þeirra sem þrombínhemla
NO974403L (no) Reversible proteasehemmere
IS5302A (is) Nýjar amidínóafleiður og notkun þeirra sem þrombínhemla
ATE268781T1 (de) Thrombininhibitoren
BR9610075A (pt) Inibidores prolil endopeptidase
NO975415L (no) Basiske koboltholdige karbonater, fremgangsmåte for fremstilling og anvendelse derav
NO992690D0 (no) Nye calpainer, fremstilling og anvendelse derav
NO20003268D0 (no) Hyperhydrert kitikolin, fremgangsmÕte og anvendelse
ATE282629T1 (de) Thrombininhibitoren
FI981659A0 (fi) Uusi menetelmä ja tuote
NO995985L (no) Nye karbohydrater og anvendelse derav